
Organon Reports Positive Interim Phase 3 Results for MIUDELLA® Through Six Years of Use
Organon Announces Positive Interim Phase 3 Study Results for MIUDELLA®, a Hormone-Free, Intrauterine Device (IUD), Through 6 Years of Use to Be Presented at the 2026 Society of Family Planning Annual Meeting Organon a global healthcare company with a mission…














